SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-089143
Filing Date
2020-07-31
Accepted
2020-07-31 16:55:50
Documents
1
Period of Report
2020-07-29

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 5769
  Complete submission text file 0001104659-20-089143.txt   7231
Mailing Address C/O OPTIMER PHARMACEUTICALS, INC 101 HUDSON STREET SAN DIEGO CA 07302
Business Address
Webster Stephen W (Reporting) CIK: 0001438421 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37558 | Film No.: 201066674

Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Issuer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences